UNIT 1: Week 2 Flashcards

(19 cards)

1
Q

Conditions that warrant the use of EPAs

A

Pain, Swelling, Skin conditions, Tendon impairments, Muscle impairments, Neurological impairments, Bone/joint impairments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Categories of EPAs

A

Thermal, Mechanical, Electric, Electromagnetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Examples of Thermal EPAs

A

Hot packs, Ice packs, Ultrasound, Whirlpool, Short wave diathermy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of Mechanical EPAs

A

Hydrotherapy, Ultrasound, Traction, Shockwave

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Examples of Electric EPAs

A

TENS, IFC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Examples of Electromagnetic EPAs

A

UV radiation, Infrared radiation, Laser, Diathermy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a key consideration about EPAs?

A

Some physical agents fall into more than one category (e.g., water and ultrasound both have thermal and mechanical effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why use EPAs during the inflammatory phase?

A

Reduce circulation, pain, muscle tone, enzymatic activity rate; Control motion; Promote progression to proliferation phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do thermal agents modify inflammation and healing?

A
  • affect circulation
  • affect enzymatic rate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do mechanical agents modify inflammation and healing?

A
  • control motion
  • alter fluid flow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do electromagnetic agents impact inflammation and healing?

A
  • alter cell function (increase cell permeability and transport)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why use EPAs during the proliferation phase?

A

Increase circulation, enzymatic activity rate; Promote collagen deposition, progression to remodeling phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why use EPAs during the maturation phase?

A

Alter balance of collagen deposition and resorption; Improve alignment of new collagen fibres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Contraindications/precautions to use of EPAs

A
  • circulatory impairment
  • pacemaker
  • pregnancy
  • seizure disorder
  • fracture
  • active hemorrhage
  • malignancy
  • decreased skin sensation
  • confusion
  • cold allergy
  • metal implants
  • obesity
  • open wounds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Framework for delivering EPAs

A
  1. Patient
    2.Prepare and test EPA
  2. Apply
  3. Terminate treatment
  4. Document
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What must be included in documenting EPAs?

A

Modality, Where applied, Duration of application, Dose used, Patient positioning

17
Q

Considerations for selecting the most appropriate EPA

A
  • goals of patient
  • goals of intervention
  • physiological effects required to reach goals
  • which modality is effective for goals
  • contraindications/precautions
18
Q

How can EPAs reduce pain?

A
  • modifying pain transmission or perception
  • affecting cellular processes that cause pain
  • modifying tissue inflammation
  • altering collagen extensibility
19
Q

How can EPAs alter muscle tone?

A
  • nerve conduction (nerves fire slower)
  • nerve sensitivity (nerve threshold can increase)
  • muscles can be more fluid